Navigation Links
Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting
Date:5/24/2011

ATLANTA and CHICAGO, May 24, 2011 /PRNewswire/ -- For the fifth straight year, Elekta has been selected to demonstrate at the American Society of Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June 4-6, at McCormick Place in Chicago. In the spotlight will be Elekta's MOSAIQ® Oncology Information System, the first and only oncology-specific comprehensive EMR certified for Meaningful Use under the federal government's HITECH Act. MOSAIQ is fully prepared for centers planning attestation in 2011 or 2012.

Elekta is among 12 providers chosen to present at the EHR Lab, a forum for ASCO members to discover the latest EHR technology. With nearly 30,000 members, ASCO is the world's leading professional organization representing physicians who care for people with cancer.

Elekta's integrated Oncology Information Systems features a complete, patient-centric chart optimized for medical oncology, radiation oncology and comprehensive practices. During the Lab, Elekta clinical experts will be available to provide hands-on demonstrations of MOSAIQ, and show how this unique, single-database EHR can perform clinical decision support, chemotherapy ordering and Quality Oncology Practice Initiative (QOPI®) case selection.

"Elekta has repeatedly demonstrated and followed through on its commitment to deliver a comprehensive and robust oncology-specific EHR and to support emerging healthcare trends," says Grant Spencer, Vice President, Product Creation, Oncology Information Systems. "For example, Elekta was a leader in support of government initiatives by offering the first comprehensive EHR to receive complete ONC-ATCB certification, and we were ready to implement ICD-10 diagnosis codes years ahead of the deadlines. Elekta is committed to the delegates of ASCO, our customers and clinical partners by providing efficient, streamlined workflows that allow them to focus on patient care."

To download a
'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
4. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
5. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
6. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
7. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
8. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
9. Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center
10. Elekta Demonstrates Continued Leadership in Image Guidance at 2009 ASTRO Annual Meeting
11. Elekta Expands Consultative Services Program to Help MOSAIQ Customers Demonstrate Meaningful Use Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015  IP Shakti, LLC, today announced that ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... "Our new corporate identity signifies our transformation into a company ... analytics platform for patent claim validity." ... the proprietary AIA Shield™ platform, the Company commenced a corporate ...
(Date:8/28/2015)... South Korea , Aug. 28, 2015 ... National University and Dr. Ra from Biostar , ... , Confirmed 30% increase of lifespan through multiple IV ... function, physical vitality, and life expectancy found , ... in Korea have determined the possibility that adult mesenchymal ...
(Date:8/27/2015)... Aug. 27, 2015  The Academy of Managed ... Drug Administration,s (FDA,s) draft guidance and proposed rule ... biosimilars, to bear a nonproprietary name with an ... seeking a decision from the FDA on the ... care stakeholders urging the agency to use the ...
Breaking Medicine Technology:IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... subsequently,respond, have substantially more treatment costs, and ... COLORADO SPRINGS, Colo., April 03, 2007 /PRNewswire-FirstCall/,-- ... Congress on,Schizophrenia Research (ICOSR) suggest that antipsychotic ... thought, and,challenge the current schizophrenia treatment paradigm ...
... Amyloid Plaque Formation, ANNAPOLIS, Md., April 03, ... company specializing in the development,and commercialization of ... today that new data from its,recombinant butyrylcholinesterase ... 8th International Conference on,Alzheimer's and Parkinson's Diseases ...
Cached Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of furthering music education programs ... to the Adams County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once ... music education in the underfunded school districts of Mendon and its neighboring town of ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ones of a person ... with chemical dependency, may be able to find some hope in the latest ... center for addiction located in Western Michigan. Focusing on several different aspects of ...
(Date:8/28/2015)... ... , ... Altima Technologies, Inc., the maker of popular NetZoom™ ... and audio-video devices, recently released Visio Stencils for the following product lines: ... VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems Virtual Storage Series, ...
(Date:8/28/2015)... ... 28, 2015 , ... The Nashville Business Journal recently announced ... business. Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one ... Veterans Awards will recognize Nashville military veterans who, through their professional and personal ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:MyGenetx Board Member Receives Veterans Award 2
... severe or fatal complications, but 10󈝻 per cent never ... in the PROLONG study", explains Valeriya Lyssenko, who along ... leads the PROLONG study. Stiff sugary arteries:,Despite decades ... are not yet fully known. Neither is it possible ...
... for Remote Underserved Minority Populations in the Pacific Region ... National Institute for Food and Agriculture (NIFA). The ... and other jurisdictions of the US including: Alaska, American ... Federated States of Micronesia, Hawaii, Palau, and the Republic ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay News) -- ... at night with Fido or Fluffy. According to a ... journal Emerging Infectious Diseases , seemingly healthy pets can ... illness in people. Of the 250 zoonotic diseases -- ...
... FRIDAY, Jan. 21 (HealthDay News) -- The first letter of ... adult, according to a new study. U.S. researchers examined ... wanted, and they found that those with childhood last names ... alphabet tended to be the quickest purchasers. However, this ...
... Bipolar Clinic and Research Program with the Bipolar ... Outcomes Initiative in Comparative Effectiveness), a 10-site nationwide ... quetiapine, a widely prescribed second generation antipsychotic mood ... mood stabilizer, for the treatment of outpatients with ...
... THURSDAY, Jan. 20 (HealthDay News) -- Many young American couples ... with each other, a new study shows. Oregon State ... non-married couples, aged 18 to 25. In 40 percent of ... be monogamous while the other partner said there was no ...
Cached Medicine News:Health News:Why do some diabetics escape complications? 2Health News:Pets May Pass Illnesses to Owners 2Health News:Pets May Pass Illnesses to Owners 3Health News:Childhood Last Name Predicts Whether You Buy Early, Late: Study 2Health News:Massachusetts General Hospital leading nationwide, comparative study of common bipolar medications 2Health News:Young Couples Often Disagree About Monogamy, Study Finds 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: